Uptake of MnCl2 and Mangafodipir Trisodium in the Myocardium: A Magnetic Resonance Imaging Study in Pigs

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 5, 2004, Pages 564-569

  Eriksson, Rolf ^a   Johansson, Lars ^a,b   Bjerner, Tomas ^a   Saebo, Karen Briley ^a,b   Ahlström, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Amersham Health   (Norway)

Author keywords

Agent; Contrast; Magnetic resonance; Manganese; Myocardium; Relaxation

Indexed keywords

MANGAFODIPIR; MANGANESE CHLORIDE; CONTRAST MEDIUM; DRUG DERIVATIVE; EDETIC ACID; MAGNESIUM CHLORIDE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISSOCIATION; DISSOCIATION KINETICS; DRUG METABOLISM; DRUG UPTAKE; HEART MUSCLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE; ANIMAL; BLOOD; FEMALE; MALE; METABOLISM;

ANIMALS; CONTRAST MEDIA; EDETIC ACID; FEMALE; MAGNESIUM CHLORIDE; MAGNETIC RESONANCE IMAGING; MALE; MODELS, ANIMAL; MYOCARDIUM; PYRIDOXAL PHOSPHATE; SWINE;

EID: 2442628150     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20038     Document Type: Article

References (24)

1. Higgins CB. Cardiac imaging. Radiology 2000;217:4-10.
2. Wagner A, Mahrholdt H, Holly TA. Contrast enhanced MRI and routine photon emission computer tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379.
3. Sandstede JJW. Assessment of myocardial viability by MR imaging. Eur Radiol 2002;13:52-61.
4. Sandstede JJW, Beer M, Hofmann S, et al. Changes in left and right ventricular cardiac function after valve replacement for aortic stenosis determined by cine MR imaging. J Magn Reson Imaging 2000;12:240-246.
5. Miller DD, Holmvang G, Gill JB, et al. MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia. Magn Reson Med 1989;10:246-255.
6. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383.
7. Sinitsyn V. Magnetic resonance imaging in coronary heart disease. Eur J Radiol 2001;38:191-199.
8. Mendonca-Dias HM, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983;13:364-376.
9. Tirkkonen B, Aukrust A, Couture E, et al. Physicochemical characterisation of mangafodipir trisodium. Acta Radiol 1997;38:780-789.
10. Bremerich J, Saeed M, Arheden H, Higgins CB, Wendland MF. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Radiology 2000;216:524-530.
11. Hu TC, Pautler RG, MacGowan GA, Koretsky AP. Mangenese-enhanced MRI of mouse heart during changes in inotropy. Magn Reson Med 2001;46:884-890.
12. Flacke S, Allen JS, Chia JM, et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology 2003;226:731-738.
13. Delahayes JF. Depolarization-induced movement of Mn2+ across the cell membrane in the guinea pig myocardium. Circ Res 1975;36:713-718.
14. Prasad PV, Post M, Storey P, et al. Preliminary evaluation of EVP 1001-1: a new cardiac specific MR contrast agent with optimal kinetics for evaluation of the ischemic heart. In: Proceedings of the 8th Annual Meeting of ISMRM, Denver, 2000. p 1593.
15. Gerber GB, Léonard A, Hantson P. Carcinogenicity, mutagenicity and teratogenicity of manganese compounds. Crit Rev Oncol Hematol 2002;42:25-34.
16. Gavin CE, Gunter KK, Gunter TE. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 1999;20:445-454.
17. Schmidt PP, Toft KG, Skotland T, Andersson KK. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR. J Biol Inorg Chem 2002;7:241-248.
18. Brurok H, Schojtt J, Berg K, Karlsson JOG, Jynge P. Effects of manganese dipyroxidyl diphosphate, dipyroxidyl diphosphate, and manganese chloride on cardiac function. Invest Radiol 1995:30:159-167.
19. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1969;41:250-251.
20. Karlsson JOG. Brurok H, Eriksen M, et al. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol 2001;42:540-547.
21. Brurok H, Berg K, Sneen L, Grant D, Karlsson JOG, Jynge P. Cardiac metal contents after infusions of manganese: an experimental evaluation in the isolated rat heart. Invest Radiol 1999;34:470-476.
22. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharmacol Res 1993;10:1093-1095.
23. Saeed M, Higgins CB, Geschwind JF, Wendland MF. T1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur Radiol 2000;10:310-318.
24. Lauffer R. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987:87:901-927.